Pericarditis Market:
Pericarditis Market was valued at USD 3.2 Billion in 2021, registering a CAGR of 5.2% during the forecast period (2022-2030), and the market is projected to be worth USD 5.05 Billion by 2030. Pericarditis is a cardiovascular disease that causes swelling and irritation of the sac-like tissue called pericardium which covers the outer surface of the heart. The pericarditis disease is expected to last for a few weeks or several months which varies in each case. The increased prevalence of cardiovascular diseases in the population over a decade is the major factor contributing to the growth of the pericarditis market. For instance, in 2017, the American Heart Association reported that nearly 92.1 million Americans were diagnosed with cardiovascular diseases. The study also emphasized the high prevalence of these diseases in men than in women owing to the major symptoms of heart diseases such as strokes, chest pain, and heartburn.
According to the data published by the World Health Organization, cardiovascular disease is one of the deadly diseases which kills approximately 17.9 million people worldwide each year. In the case of the pericarditis market, the rising number of recurrent pericarditis incidences is expected to increase the growth of the pericarditis market during the forecast period. For instance, according to the data from the 2016 National Readmission Database, approximately 400 cases were related to recurrent pericardial diseases out of the overall 3000 cases. The diseases such as pleural effusion, arrhythmias, and sepsis are the major factors contributing to the readmission of patients.
Pericarditis Market Dynamics:
Pericarditis is defined as the inflammation of a thin, fluid-filled, two-layered sac that surrounds the outer surface of the heart. The major symptoms of pericarditis disease are sharp chest pain, low-grade fever, shortness of breath when lying down, leg swelling, and others. Furthermore, factors such as radiation therapy and chronic illnesses like diabetes, heart disease, and arthritis are also expected to trigger renal failure and bacterial infections in severe pericarditis cases.
Driver:
The globally rising and recurring rates of cardiovascular diseases such as heart valve imbalance, arrhythmia, and atrial fibrillation, growing numbers of geriatric population, and increased awareness of such cardiovascular diseases are driving the growth of the pericarditis market. Moreover, the increased sedentary lifestyle incidences combined with the rise in smoking and alcohol consumption are major risk factors for cardiovascular diseases that drive the growth of the pericarditis market.
Restraint:
The stringent regulations and policies from the government, a large presence of misbranded drug interventions combined with a few unproven surgical interventions are expected to hamper the market growth. Additionally, the rising healthcare costs in terms of cardiovascular diseases, and delays in research and developmental studies are anticipated to hinder the growth of the pericarditis market.
Opportunity:
The rise in prevalence of idiopathic pericarditis with recurrent episodes is anticipated to generate profitable opportunities such as the adoption of dual therapy of aspirin with colchicine and increased clinical trials that fuel the market growth. Furthermore, increased awareness of cardiovascular disease assessment and relevant medical treatment innovation in the field is expected to offer lucrative opportunities for the growth of the pericarditis market.
COVID-19 Analysis of Pericarditis Market:
The pericarditis market has been significantly impacted due to the COVID-19 pandemic in many different parts of the world. The factors such as poor supply chain, slow medical device manufacturing rate, limited availability of raw materials, and economic slowdown are the major impacts of COVID-19 that hampered the growth of the pericarditis market. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a manufacturing facility. The pandemic’s initial effects in China were tremendous. However, the nation’s circumstances have stabilized. As a result, it is determined that COVID-19’s overall impact on the pericarditis market is moderate. Post covid-19 there was a positive impact on the pericarditis market as consumers were more focused on health.
Pericarditis Market Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 5.05 Billion |
| CAGR (2022-2030) | 5.2% |
| By Type | Acute, Recurrent, Chronic, and Idiopathic |
| By Diagnosis | Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (CT) and X-Ray |
| By Treatment | Medication (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Colchicine) and Surgical Treatment |
| By End-Use | Hospitals & Clinics, Ambulatory Surgical Centers, and Academic & Research Institutes |
| By Geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | Johnson & Johnson Services, Inc., Novartis International AG., PerkinElmer Inc., AstraZeneca Plc., Bayer, Reckitt Benckiser, Fujifilm, Merck Sharp, and Dohme, Allergan Plc., Pfizer Inc. |
Pericarditis Market Segment Analysis:
By Type
The type segment is divided into acute, recurrent, chronic, and idiopathic pericarditis. The acute pericarditis segment is estimated to contribute the largest share of the market due to the factors such as common occurrence and fewer complications. Acute pericarditis is the painful inflammation of the outer fluid-filled pouch which surrounds the heart. Additionally, the risk factors such as cancer, infections, or heart surgery are expected to support the acute pericarditis segment growth in the forecast period. The chronic pericarditis segment is also anticipated to witness significant growth in the forecast period. The inflammation of the pericardium lasts for three months or longer duration due to the gradual development of the disease indications. The most common chronic pericarditis symptoms are stabbing pain behind the breastbone or on the left side of the chest, coughing, fatigue, and severe shortness of breath.
By Diagnosis
The diagnosis segment is separated into electrocardiogram (ECG), echocardiogram, computerized tomography (CT), and x-ray. The electrocardiogram (ECG) segment is anticipated to contribute the largest share contribution to the growth of the pericarditis market. The ease of acute pericarditis diagnosis through ST-segment elevation and PR-segment depression is estimated to strengthen the contribution of the electrocardiogram (ECG) segment in the market growth. Further, the echocardiogram is anticipated to support the market growth due to the precise imaging of the heart using ultrasound waves to check for fluid buildup around the heart. Thus, echocardiogram, computerized tomography (CT), and x-ray segments are also anticipated to support the growth of the pericarditis market owing to continuous tests and check-ups for heart monitoring purposes.
By Treatment
The treatment segment is classified into medication and surgical treatment. The medication segment is expected to contribute the largest share of the market growth during the estimated period. The medication segment is further sub-segmented into non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine. The most common acute pericarditis is treated within the duration of two to four weeks using a nonsteroidal anti-inflammatory drug (NSAID). Additionally, colchicine with weight-adjusted dosing is administered for the prevention of recurrent pericarditis. In extreme cases, the low doses of corticosteroids are reserved for those patients who had no visible effects of multiple therapy attempts with an NSAID plus colchicine dosage.
By End-Use
The end-user segment is categorized into hospitals & clinics, ambulatory surgical centers, and academic & research institutes. In 2020, the hospital & clinics segment held the leading market value of USD 974.50 million in the pericarditis market. The factors such as favorable reimbursement policies combined with the rise in advanced medical devices are expected to augment the growth of the hospitals & clinics segment during the projected period. The academic & research institutes are anticipated to witness significant growth during the forecast period owing to the increased expenditures on research and development studies to understand the core of pericarditis. Thus, the above-mentioned segments are expected to accelerate the growth of the pericarditis market in the forecast period.
By Region
The regional segment includes Asia Pacific, Europe, North America, Middle East, and Africa, Latin America. In 2021, North America had the largest share in the growth of the Pericarditis market. The factors such as the presence of high-quality healthcare infrastructure and a large medical network are expected to support the growth of the North American region. Additionally, the rising number of cardiac disorders incidences and increased investments in research and development are also anticipated to boost the growth of the pericarditis market in the North American region.
The Asia Pacific is expected to dominate the growth of the pericarditis market during the forecast period. Further, China led the growth of the market due to the rise in the numbers of geriatric population, developing healthcare infrastructure, and increased prevalence of pericarditis diseases that fuel the market growth in the Asia Pacific region.
Pericarditis Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Application launches have accelerated the growth of the Sample Preparation market. Key players in the market include-
- Johnson & Johnson Services, Inc.
- Novartis International AG.
- PerkinElmer Inc.
- AstraZeneca Plc.
- Bayer
- Reckitt Benckiser
- Fujifilm
- Merck Sharp and Dohme
- Allergan Plc.
- Pfizer Inc.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Pericarditis
- Global Pericarditis Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Pericarditis Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Distribution Channel
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Technology Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Pericarditis demand
- Post-Covid Impact on Pericarditis Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Pericarditis Market Segmentation, by Revenue (USD Billion), (2022-2030)
- By Type
- Acute
- Recurrent
- Chronic
- Idiopathic
- By Diagnosis
- Electrocardiogram (ECG)
- Echocardiogram
- Computerized Tomography (CT)
- X-Ray
- By Treatment
- Medication
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Colchicine
- Surgical Treatment
- Medication
- By End Use
- Hospitals & Clinics
- Ambulatory surgical centers
- Academic & Research Institute
- By Type
- Global Pericarditis Market Overview, By Region
- North America Pericarditis Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Type
- By Diagnosis
- By Treatment
- By End Use
- Canada
- Mexico
- US
- Europe Pericarditis Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Pericarditis Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Pericarditis Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Pericarditis Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Pericarditis Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Pericarditis Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Johnson & Johnson Services, Inc.
- Business Overview
- Business Financials (USD Billion)
- Product Category, Type, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Novartis International AG.
- PerkinElmer Inc.
- AstraZeneca Plc.
- Bayer
- Reckitt Benckiser
- Fujifilm
- Merck Sharp and Dohme
- Allergan Plc.
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.